Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T04:00:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T08:17:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content with a generic error page. Access to the study details is blocked, though the site chrome (header/footer) remains visible.
    Difference
    21%
    Check dated 2026-09-20T03:06:37.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-08-29T19:44:14.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page; no study content appears to be altered.
    Difference
    0.0%
    Check dated 2026-08-08T10:21:03.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.3 to v3.6.4, indicating a minor software update. There are no visible changes to the study details or layout resulting from this revision.
    Difference
    0.0%
    Check dated 2026-07-25T06:22:24.000Z thumbnail image

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.